Kaya Holdings (KAYS) Equity Ratio (2011 - 2025)

Kaya Holdings (KAYS) recorded quarterly Equity Ratio of 13.65 in Q3 2025, up 83.69% quarter-over-quarter from 83.66 in Q2 2025, and up 79.82% on a YoY basis from 7.59 in Q3 2024.

Kaya Holdings (KAYS) Equity Ratio (2011 - 2025) Analysis & Trends

Kaya Holdings' Equity Ratio history runs 15 years deep, the most recent figure standing at 13.65 for Q3 2025.

  • In Q3 2025, Equity Ratio rose 79.82% year-over-year to 13.65; the TTM figure through Sep 2025 stood at 13.65 (up 79.82% YoY), while the FY2024 annual figure was 79.16, down 8.49% from the prior year.
  • Equity Ratio was 13.65 for Q3 2025 at Kaya Holdings, up from 83.66 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 7.66 in Q3 2021 to a low of 95.28 in Q1 2025.
  • Historically, Equity Ratio has averaged 44.46 across 5 years, with a median of 54.8 in 2024.
  • The sharpest annual moves came in 2023 and 2025: Equity Ratio sank 460.64% in 2023, then soared 79.82% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 9.18 in 2021, then tumbled by 127.36% to 20.88 in 2022, then plunged by 249.52% to 72.97 in 2023, then dropped by 8.49% to 79.16 in 2024, then jumped by 82.76% to 13.65 in 2025.
  • The last three Equity Ratio figures came in at 13.65 (Q3 2025), 83.66 (Q2 2025), and 95.28 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 0.21
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 0.21
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 0.88
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 0.73
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 0.69
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 0.49
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 0.41
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 0.52
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 0.20
10 Kaya Holdings - - 5,370.00 -13.65

Historic Data

Download Data
DateValue
Sep 30, 2025 -13.65
Jun 30, 2025 -83.66
Mar 31, 2025 -95.28
Dec 31, 2024 -79.16
Sep 30, 2024 -67.62
Jun 30, 2024 -54.80
Mar 31, 2024 -74.01
Dec 31, 2023 -72.97
Sep 30, 2023 -69.35
Jun 30, 2023 -70.61
Mar 31, 2023 -57.13
Dec 31, 2022 -20.88
Sep 30, 2022 -20.67
Jun 30, 2022 -12.59
Mar 31, 2022 -13.15
Dec 31, 2021 -9.18
Sep 30, 2021 -7.66
Jun 30, 2021 -9.17
Mar 31, 2021 -13.23
Dec 31, 2020 -10.84